Delivery Order SPE2DB22D2006-SPE2DB24FV7TM
- Not listed
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,348.08 firm-fixed-price delivery order contract covers the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical commodity, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply CEFAZOLIN 1 G/50 ML-DEXTROSES. The $2,904.77 firm fixed-price delivery order has a completion date of July 23, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of May 23, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,715.76. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a key customer for Amerisourcebergen. The award is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical product, with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,426.26 firm fixed-price delivery order is for the supply of 4565256342, which appears to be a medical product called CEFAZOLIN 2 G/50 ML-DEXTROSES. This award is not associated with a set-aside program. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,311.44 firm fixed-price delivery order is for the supply of 4563154732 CEFAZOLIN 1 GM VIALS, a medical product used in healthcare settings. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,187.46 for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES. The contract is a Firm Fixed Price arrangement with the Defense Logistics Agency (DLA) Troop Support Medical, and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,047.60, is a Firm Fixed Price Delivery Order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSE medical products. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,882.49 firm fixed-price delivery order is for the supply of Cefazolin 2 G/50 ML-Dextrose, a pharmaceutical product. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.46 Firm Fixed Price delivery order contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV7TMDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.16 firm fixed-price delivery order is for the supply of 4563463523 ! CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2024. No set-aside was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/28/24 |